SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending due to heightened volatility and bearish sentiment fueled by accusations that the company illicitly accessed AI models from a U.S.-based lab, while investors remain divided between those betting on a deep-value reversal and those fearing further regulatory and delisting risks.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is experiencing high volatility as investors weigh the appointment of a new CFO and a positive tariff refund surprise against ongoing concerns over market share and long-term brand execution. Community sentiment is deeply polarized, with many retail traders debating whether the stock is a structural value trap or a generational buying opportunity ahead of their upcoming earnings report.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing explosive, momentum-driven gains as investors bet on a persistent NAND flash supply supercycle fueled by relentless AI infrastructure demand. While the stock continues to hit record highs following positive industry earnings, the community remains sharply divided between those riding the historic rally and others warning of extreme overvaluation and inevitable mean reversion.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors interpret a recent regulatory filing concerning executive change-of-control agreements as strategic preparation for a potential buyout. This momentum is further fueled by significant short-covering pressure and heavy community speculation regarding an imminent Phase 3 clinical trial readout.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is experiencing significant downward pressure as market sentiment shifts, leading to a broader repricing of high-valuation AI software stocks. Investors are actively debating the stock's future, with some interpreting the recent price decline as a necessary correction for a premium valuation while others closely monitor reports surrounding prominent short positions and sector-wide volatility.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and significant selling pressure, fueled by investor anxiety over potential securities litigation and the company's leveraged exposure to Bitcoin. The community remains deeply polarized, with bulls viewing the decline as a generational buying opportunity while bears and short-sellers argue that the current business model is unsustainable.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending as investors debate the impact of AI on its core design platform, with bullish community members highlighting recent product enhancements, strong revenue growth, and an optimistic analyst initiation despite the stock's recent downtrend. Bears and shorts remain active, however, citing concerns over market competition, intense selling pressure, and skepticism regarding the company's long-term profitability.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma (HELP) is experiencing significant volatility and downward pressure following the release of Phase 2 data for its HLP004 anxiety program, which investors are weighing against its Breakthrough Therapy-designated HLP003 pipeline. Community sentiment is deeply divided as the stock trades near cash value, with active discussions debating whether this is a distressed entry point for a sector buyout or a sign of deeper management and financial risks.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors react to a strong earnings beat and raised full-year revenue guidance, which management attributed to high adoption of its dialysis product, DefenCath. While the stock has seen significant volatility, the community is actively debating the impact of upcoming reimbursement transitions, the potential for institutional accumulation, and whether recent growth momentum justifies a valuation re-rating.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's has become a focal point for retail investors seeking a potential short squeeze, fueled by viral meme activity and speculation regarding a future acquisition or turnaround strategy. While community sentiment remains divided between hopeful bulls targeting triple-digit gains and skeptics warning of a pump-and-dump, the high trading volume and elevated interest in the company's valuation continue to drive intense discussion across social media.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ARBE Do your DD: 
 
Top 10 OEM Win from 2024: 
https://ir.arberobotics.com/news/press-releases/detail/127/arbe-selected-by-top-oem-for-the-development-of-imaging 
 
Debentures: 
https://ir.arberobotics.com/news/press-releases/detail/163/arbe-announces-proposed-extension-of-convertible-debenture 
 
Arbe has $32.8M in debentures total that will get unlocked if they hit 3 gates before end of December, 2026. 
 
1:  &quot;The Company wins a tender or contract to supply its products as a single supplier of chips of imaging radar (directly or through one of the international Tier 1 manufacturers) to one of ten named major automobile manufacturers.&quot; 
 
2: &quot;The average closing trading price of Arbe&#39;s ordinary shares on Nasdaq is not less than $3.10 per share during 30 consecutive trading days, and the average combined trading volume on Nasdaq and TASE during such 30 trading days is at least 300,000 shares per day.&quot; 
 
3: &quot;The closing price of the Company&#39;s ordinary shares on Nasdaq on the date the Company presents to the trustee the documentation confirming the fulfillment of the abovementioned conditions precedent, is not less than $3.10.&quot;

jack stirling

smolawoo

TEL AVIV, Israel, July 1, 2024 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) (TASE: ARBE), a global leader in Perception Radar solutions, today announced that one of the top ten OEMs worldwide has selected Arbe's chipset for the development of its next-generation imaging radar aimed at serial production.

Arbe Robotics Ltd.

Arbe Selected by Top OEM for the Development of Imaging Radar for Production

TEL AVIV, Israel, Dec. 8, 2025 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) (TASE: ARBE) ("Arbe" or the "Company"), a global leader in perception radar solutions, today announced that, subject to approval of the bondholders, it proposes to extend to December 31, 2026 the deadline for meeting the conditions under its series A convertible bonds for the release of the proceeds raised from the issuance of the convertible bonds which proceeds are held by the trustee.

Arbe Announces Proposed Extension of Convertible Debenture Milestones

$ARBE with current price, Arbe can&#39;t afford to dilute.  They also are searching for a new CFO... No CFO, No dilution events. 
 
If Arbe has a terrible, no good, bad year for the remainder of 2026, they&#39;ll end up filing for a 180 day extension with NASDAQ with a guaranteed reverse stock split to be executed at the end of the 180 extension if they fail to get the price above $1 in the next 10 months. 
 
What happens before then?  Dec 2026 debenture expiration date.  Arbe has a Top 10 OEM in the bag from July of 2024, and its one of the OEMs listed in the Debentures.  They just need that partner to name drop Arbe, and debentures are unlocked... at $2.95/share... but, Arbe needs to maintain a stock price of &gt;$3.10 for 30 consecutive trading days.  November 17, 2026 is the &quot;last day&quot; they can trade below $3.10 and still make it. 
 
Now... Is the event guaranteed to happen?  no.  Nothing is guaranteed.  However... do the math.  $.69 today... minimum $3.10 before end of year &quot;if&quot; the event happens.

StockTwits Web

Arbe Robotics Ltd

$ARBE Also keep in mind... the holders of the debentures can opt to cash out early, before the 30 trading days. 
 
If Arbe exceeds $3.10 by a large margin, some will opt to cash out early (much like what happened in Jan of 2025 on the $NVIDIA partnership news at CES.)  The holders cashed out ~$21.5M at the time. 
 
The 30 trading days is $ARBE&#39;s ace card, if any holders refuse to cash out early.  If Arbe hits the 30 days, they force the hand of the any remaining holders to convert at $2.95/share.

 Do your DD: 
 
Top 10 OEM Win from 2024: 


 
 
Arbe has $32.8M in debentures total that will get unlocked if they hit 3 gates before end of December, 2026. 
 
1:  "The Company wins a tender or contract to supply its products as a single supplier of chips of imaging radar (directly or through one of the international Tier 1 manufacturers) to one of ten named major automobile manufacturers." 
 
2: "The average closing trading price of Arbe's ordinary shares on Nasdaq is not less than $3.10 per share during 30 consecutive trading days, and the average combined trading volume on Nasdaq and TASE during such 30 trading days is at least 300,000 shares per day." 
 
3: "The closing price of the Company's ordinary shares on Nasdaq on the date the Company presents to the trustee the documentation confirming the fulfillment of the abovementioned conditions precedent, is not less than $3.10."